Notice
Recent Posts
Recent Comments
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
Tags
- Letter of intent
- case study
- OTCBB
- Korea M&A
- hong kong
- capital gate
- M&A
- Japan
- sk
- LOI
- Merger
- securities
- cgi korea
- CCB
- Japan Tobacco
- Confidential Agreement
- Bank
- Korea
- nda
- CA
- buyout
- taiwan
- China
- China Construction Bank
- Acquistion
- private equity
- acquisition
- PEF
- Malaysia
- Investment
Archives
- Today
- Total
Korea M&A Corporation
SmithKline, Glaxo merger valued at $75 billion
SmithKline, Glaxo merger valued at $75 billion January 17, 2000 SmithKline Beecham and Glaxo Wellcome agreed to merge and form the world's biggest pharmaceutical company in a deal valued at $75.7 billion. Both companies are based in London. SmithKline's U.S. headquarters is in Philadelphia; Glaxo's is in North Carolina. Under the proposed agreement, SmithKline COO Jaun-Pierre Garnier will serves..
Case Study
2006. 5. 13. 06:44